Core Laboratories Inc. (CLB) 株式分析

企業概要

Core Laboratories Inc. is a prominent player in the energy sector, specifically within the oil and gas equipment and services industry, providing reservoir description and production enhancement services alongside specialized products to clients across the United States and internationally. The company's operations are structured through its Reservoir Description and Production Enhancement segments, which focus on delivering technical solutions essential for efficient hydrocarbon extraction and well completion processes. This entity operates at a significant scale with a total market capitalization of $773.42M and generates annual revenue of $526.52M, supported by a workforce of 3,300 employees. The combination of a market cap exceeding three-quarters of a billion dollars and revenue figures surpassing half a billion dollars indicates that the firm holds a substantial position within its niche, reflecting both market trust and operational capacity to service a global customer base.

財務健全性

The financial performance of the company over the trailing twelve months demonstrates a total revenue of $526.52M, with a net income of $29.67M and an EBITDA of $66.37M. The substantial gap between the $526.52M in revenue and the $29.67M in net income reveals a cost structure where operating expenses, including the cost of goods sold and administrative costs, consume approximately 94.4% of gross revenue before interest and taxes. The free cash flow stands at $45.78M, which signifies a robust ability to generate cash beyond capital expenditure needs, providing the firm with considerable financial flexibility for strategic initiatives or debt servicing. Profitability is further dissected through three key margins: a gross margin of 20.7%, an operating margin of 10.9%, and a profit margin of 5.6%, indicating that for every dollar of sales, the company retains a small fraction as net profit after all operational and interest costs. The balance sheet shows a cash position of $22.70M against total debt of $164.02M, resulting in a debt-to-equity ratio of 60.26, which characterizes the capital structure as leveraged rather than conservative. Despite the debt load, the current ratio of 2.02 suggests strong short-term liquidity, as the company holds more than double the assets required to cover its immediate liabilities. Return metrics show a return on equity of 11.6% and a return on assets of 5.5%, which together indicate that management is utilizing shareholder equity and total assets to generate moderate returns, with equity being a more efficient source of capital than assets in this specific fiscal period.

バリュエーション評価

Valuation multiples for Core Laboratories Inc. include a trailing twelve-month P/E ratio of 26.37 and a forward P/E of 18.46, implying that the market expects earnings growth in the future that would bring the price-to-earnings multiple down from its current trailing level. The price-to-book ratio is calculated at 2.88, suggesting that the market values the company at nearly three times its book value, indicating a premium priced into the stock relative to its net asset worth. Alternative valuation metrics such as a price-to-sales ratio of 1.47 and an EV/EBITDA of 13.75 provide additional context, showing that investors are willing to pay a moderate multiple of sales and enterprise value relative to earnings before interest, taxes, depreciation, and amortization. The stock has traded within a 52-week range between a low of $9.72 and a high of $20.36, meaning the current trading price fluctuates significantly within this historical band relative to the recent volatility. The beta value of 1.16 indicates that the stock's price volatility is slightly higher than the broader market, suggesting that Core Laboratories Inc. moves with greater sensitivity to general market swings than a benchmark index.

Growth & Income

Growth dynamics for the fiscal period show a revenue growth rate of 7.0% year-over-year contrasted with an earnings growth rate of -31.6% year-over-year, indicating that earnings are currently declining at a pace much faster than revenue expansion. This divergence implies that rising costs or one-time charges are compressing profit margins despite top-line growth, resulting in a negative earnings trajectory while sales remain positive. Regarding income distribution, the company offers a dividend yield of 0.2% with a payout ratio of 6.3%, which is a very low level of distribution relative to the company's earnings. Given the low payout ratio, the company retains the vast majority of its profits, allowing it to reinvest earnings into growth initiatives rather than paying substantial dividends to shareholders. The overall growth and income profile is characterized by moderate revenue expansion but significant earnings contraction, supported by a minimal dividend yield that reflects a capital allocation strategy focused on internal growth and balance sheet management.